Daniela De Zio

14PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 15, 2026
Turning cold tumors hot: Strategies to enhance antitumor immunity.

|Aug 26, 2026
A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden.

|Feb 24, 2025
Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach.

Loulieta Nazerai, Christina Tsiavou, Lina Vardouli

|Jun 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.

Luca Di Leo, Chiara Pagliuca, Ali Kishk

|Jan 27, 2024
An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome.

Patricio Yankilevich, Loulieta Nazerai, Shona Caroline Willis

|Jul 26, 2023
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.

Tamara Bintener, Maria Pires Pacheco, Demetra Philippidou

Pageof 3

Frequent Collaborators

7 joint publications

Luca Di Leo

3 joint publications

Loulieta Nazerai

3 joint publications

Kjeld Schmiegelow

3 joint publications

Salvatore Rizza